Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 629 of 1,261
  1. US 9670492

    Modulation of prekallikrein (PKK) expression

    Ionis Pharmaceuticals, Inc. · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  2. US 9670140

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  3. US 9673409

    Phosphorescent tetradentate metal complexes having modified emission spectra

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  4. US 9669095

    Cyclosporin analogues for preventing or treating hepatitis C infection

    Enanta Pharmaceuticals, Inc. · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  5. US 9670484

    Methods and compositions

    BICYCLE THERAPEUTICS LIMITED · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  6. US 9670482

    Multispecific peptides

    BICYCLE THERAPEUTICS LIMITED · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  7. US 9670549

    Gene expression signatures of neoplasm responsiveness to therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  8. US 9670473

    Crystals of angiotensin-converting enzyme (ACE)

    ANGIODESIGN (UK) LIMITED · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  9. US 9670475

    Factor IX polypeptides and methods of use thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  10. US 9670281

    Binding-triggered transcriptional switches and methods of use thereof

    The Regents of the University of California · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  11. US 9670254

    VMP-like sequences of pathogenic Borrelia species and strains

    The Board of Regents of the University of Texas System · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  12. US 9670268

    Pharmaceutical composition and method of preparing same

    SAISEI MIRAI CLINIC · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  13. US 9670244

    Oxysterol compounds and the hedgehog pathway

    The Regents of the University of California · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  14. US 9670235

    Oligomer-foscarnet conjugates

    Nektar Therapeutics · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  15. US 9670229

    5-HT3 receptor antagonists

    Takeda Pharmaceutical Company Limited · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  16. US 9670209

    Muscarinic agonists

    ACADIA Pharmaceuticals Inc. · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  17. US 9670194

    Substituted aminopyrimidine compounds and methods of use

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  18. US 9670163

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  19. US 9669014

    Small molecule inhibitors of superoxide dismutase expression

    Northwestern University · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  20. WO 2017089458

    HEXAHYDROPYRAZINOBENZ- OU -PYRIDO-OXAZÉPINES TRANSPORTANT UN SUBSTITUANT CONTENANT DE L'OXYGÈNE ET SON UTILISATION POUR LE TRAITEMENT D'AFFECTIONS CONDITIONNÉES PAR 5-HT2C

    ABBVIE DEUTSCHLAND [DE] · Granted Jun 1, 2017 · Expires May 27, 2037

    granted
  21. US 9662349

    Dietary composition having mixed polysaccharides derived from lucid ganoderma, lycium barbarum and polygonatum sibiricum and method of its preparation

    INFINITUS (CHINA) COMPANY LTD. · Granted May 30, 2017 · Expires May 25, 2037

    granted
  22. US 9663575

    CD47 antibodies and methods of use thereof

    Inhibrx, Inc. · Granted May 30, 2017 · Expires May 25, 2037

    granted
  23. US 9663571

    Oncostatin M receptor antigen binding proteins

    Kiniksa Pharmaceuticals, GmbH · Granted May 30, 2017 · Expires May 25, 2037

    granted
  24. US 9663504

    Salts of heterocyclic modulators of HIF activity for treatment of disease

    The Board of Regents of the University of Texas System · Granted May 30, 2017 · Expires May 25, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.